semaglutide bangalore The Indian government has approved #NovoNordisk's obesity drug, Wegovy, for the treatment of #fattyliver disease. Novo Nordisk said the Central Drugs Standard Control Organisation (CDSCO) approved #Wegovy's 2.4 mg injection for Ozempic 0.25mg Injection | GLP-1
Description
The company hopes to gain a larger share of the GLP-1 market.

GLP-1 Friendly Grocery List

Heres how.

Stopping semaglutide doesn't mean regaining weight
